GB1269987A - Antacid composition - Google Patents

Antacid composition

Info

Publication number
GB1269987A
GB1269987A GB09070/69A GB1907069A GB1269987A GB 1269987 A GB1269987 A GB 1269987A GB 09070/69 A GB09070/69 A GB 09070/69A GB 1907069 A GB1907069 A GB 1907069A GB 1269987 A GB1269987 A GB 1269987A
Authority
GB
United Kingdom
Prior art keywords
antacid
composition
viscosity
gelation agent
gelation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB09070/69A
Other languages
English (en)
Inventor
Garland Richard Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB1269987A publication Critical patent/GB1269987A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB09070/69A 1968-04-18 1969-04-14 Antacid composition Expired GB1269987A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72217668A 1968-04-18 1968-04-18
US78572768A 1968-12-20 1968-12-20

Publications (1)

Publication Number Publication Date
GB1269987A true GB1269987A (en) 1972-04-12

Family

ID=27110553

Family Applications (1)

Application Number Title Priority Date Filing Date
GB09070/69A Expired GB1269987A (en) 1968-04-18 1969-04-14 Antacid composition

Country Status (15)

Country Link
JP (1) JPS4621672B1 (cg-RX-API-DMAC10.html)
AU (1) AU438147B2 (cg-RX-API-DMAC10.html)
BE (1) BE731695A (cg-RX-API-DMAC10.html)
CA (1) CA959760A (cg-RX-API-DMAC10.html)
CH (1) CH536114A (cg-RX-API-DMAC10.html)
DE (1) DE1919802A1 (cg-RX-API-DMAC10.html)
DK (1) DK127269B (cg-RX-API-DMAC10.html)
ES (1) ES366173A1 (cg-RX-API-DMAC10.html)
FI (1) FI50831C (cg-RX-API-DMAC10.html)
FR (1) FR2007475A1 (cg-RX-API-DMAC10.html)
GB (1) GB1269987A (cg-RX-API-DMAC10.html)
IL (1) IL32020A (cg-RX-API-DMAC10.html)
NL (1) NL6906087A (cg-RX-API-DMAC10.html)
NO (1) NO129077B (cg-RX-API-DMAC10.html)
SE (1) SE388356B (cg-RX-API-DMAC10.html)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1374874A3 (en) * 2002-06-14 2004-01-07 McNEIL-PPC, INC. Liquid antacid compositions
WO2003066022A3 (en) * 2002-02-04 2004-01-22 Pharmacia Corp Stable pharmaceutical composition useful for treating gastrointestinal disorders
US9486460B2 (en) 2014-04-29 2016-11-08 The Procter & Gamble Company Bismuth containing liquid pharmaceutical suspensions
US9486436B2 (en) 2014-04-29 2016-11-08 The Procter & Gamble Company Method for making bismuth containing liquid pharmaceutical suspensions
CN114732828A (zh) * 2022-04-27 2022-07-12 广西南宁百会药业集团有限公司 一种铝碳酸镁混悬液及其制备方法

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1401256A (en) * 1972-06-30 1975-07-16 Miles Lab Anticid tablet and preparation thereof
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
SE7905972L (sv) * 1979-07-09 1981-01-10 Haessle Ab Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand
WO1986005981A1 (en) * 1985-04-18 1986-10-23 Borody Thomas J Treatment of non-ulcer dyspepsia with bismuth salts
IT1215332B (it) * 1987-01-12 1990-02-08 Crinos Industria Farmaco Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
DE3812378A1 (de) * 1988-04-14 1989-10-26 Theo Mertens Mobile erntegutmahl- und -mischvorrichtung
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
DE4305919A1 (de) * 1993-02-26 1994-09-01 Ruediger Potthoff Transportsilo für Kunststoff-Granulat
WO2003074086A1 (fr) * 2002-03-04 2003-09-12 Medrx Co., Ltd. Matrice liquide a transfert de phase in vivo, et preparations liquides orales

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621147A (cg-RX-API-DMAC10.html) *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003066022A3 (en) * 2002-02-04 2004-01-22 Pharmacia Corp Stable pharmaceutical composition useful for treating gastrointestinal disorders
US7135197B2 (en) 2002-02-04 2006-11-14 Pharmacia Corporation Stable pharmaceutical composition useful for treating gastrointestinal disorders
EP1374874A3 (en) * 2002-06-14 2004-01-07 McNEIL-PPC, INC. Liquid antacid compositions
AU2003204688B2 (en) * 2002-06-14 2008-04-10 Mcneil-Ppc, Inc. Liquid antacid compositions
US9486460B2 (en) 2014-04-29 2016-11-08 The Procter & Gamble Company Bismuth containing liquid pharmaceutical suspensions
US9486436B2 (en) 2014-04-29 2016-11-08 The Procter & Gamble Company Method for making bismuth containing liquid pharmaceutical suspensions
US10034888B2 (en) 2014-04-29 2018-07-31 The Procter & Gamble Company Method for making bismuth containing liquid pharmaceutical suspensions
US10039835B2 (en) 2014-04-29 2018-08-07 The Procter & Gamble Company Bismuth containing liquid pharmaceutical suspensions
US10532063B2 (en) 2014-04-29 2020-01-14 The Procter & Gamble Company Method for making bismuth containing liquid pharmaceutical suspensions
US10632200B2 (en) 2014-04-29 2020-04-28 The Procter & Gamble Company Bismuth containing liquid pharmaceutical suspensions
CN114732828A (zh) * 2022-04-27 2022-07-12 广西南宁百会药业集团有限公司 一种铝碳酸镁混悬液及其制备方法

Also Published As

Publication number Publication date
NL6906087A (cg-RX-API-DMAC10.html) 1969-10-21
AU5353969A (en) 1970-10-22
ES366173A1 (es) 1971-04-01
IL32020A0 (en) 1969-06-25
CA959760A (en) 1974-12-24
AU438147B2 (en) 1973-07-18
DK127269B (da) 1973-10-15
SE388356B (sv) 1976-10-04
FR2007475A1 (cg-RX-API-DMAC10.html) 1970-01-09
IL32020A (en) 1972-11-28
JPS4621672B1 (cg-RX-API-DMAC10.html) 1971-06-19
FI50831C (fi) 1976-08-10
NO129077B (cg-RX-API-DMAC10.html) 1974-02-25
BE731695A (cg-RX-API-DMAC10.html) 1969-10-20
FI50831B (cg-RX-API-DMAC10.html) 1976-04-30
CH536114A (fr) 1973-04-30
DE1919802A1 (de) 1969-11-06

Similar Documents

Publication Publication Date Title
ES366173A1 (es) Un procedimiento para la preparacion de una composicion an-tiacida con un ingrediente muy activo.
AU697767B2 (en) Topically applicable pharmaceutical composition, process of manufacture, and use of the composition
US3740421A (en) Polyoxyethylene-polyoxypropylene aqueous gels
US6126926A (en) Whitening powder
US3395215A (en) Pressurized lotion composition
US3171752A (en) Contact lens treating solution
US2550622A (en) Ointment base and iodine ointment
GB1340516A (en) Ophthalmic solution
KR102309504B1 (ko) 안정화된 규산염 조성물 및 발한억제 조성물로서 이의 용도
ES439113A1 (es) Procedimiento para preparar productos farmaceuticos de pene-tracion a traves de la piel.
JPS614760A (ja) ヒアルロン酸塩−ポリ（エチレンオキサイド）組成物及びその化粧用製剤
US3748276A (en) Aqueous gel composition containing polyether polyol gelling agents
KR950700072A (ko) 클린다마이신과 벤조일 페록사이드를 함유한 좌창 치료용 조성물(Composi-tions of clindamycin and benzoyl peroxide for acne treatment)
JPH01156906A (ja) スキンコンデイショニングエアゾールフオーム組成物
GB1465665A (en) Topical composition
DE69401502D1 (de) Arzneizubereitung zum Herstellen eines stabilisierten Pulvers das eine Kombination aus Acetylsalicylsäure und Metoclopramid als Wirkstoff enthält
US2784100A (en) Calcium cyclamate tablet and process of making the same
DE3866198D1 (de) Pharmazeutische zubereitung fuer die intrarektale verabreichung von calcitonin und daraus hergestellte einzeldosisformen.
JPH05505405A (ja) アメトカインを含有する医薬組成物
US2771395A (en) Aqueous alcoholic hair grooming preparation employing sodium carboxymethyl cellulose
US2798816A (en) Permanently sterilized dental material
GB1132576A (en) X-ray contrast media
US2738300A (en) Stable aqueous penicillin preparation
JP3105302B2 (ja) クリーム基剤
IL94605A0 (en) Substituted aminoalkylbenzene derivatives,their manufacture and pharmaceutical compositions containing them